Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
BIOMARIN PHARM Add to My Watchlist (NSDQ: BMRN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     BioMarin 19.17 - (+0.00%) 2,043,457
105 Digital Drive
Novato, CA 94949 US
(415) 506-6700
(415) 382-7889 fax
www.biomarinpharm.com
CEO Jean-Jacques Bienaime
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US09061G1013
CIK Number 1048477
NAICS Code 325412
Business Summary
The Company develops and commercializes biopharmaceuticals for serious diseases and medical conditions.
Number of Employees 649
Share Fundamentals
Market Cap 1.93B
Shares Outstanding 100.73M
Float 97.58M
Short Interest 9.63M
Financial Strength
Revenue (TTM) $336,850,000
Earnings (TTM) $19,306,000
Quick Ratio 6.7:1
Current Ratio 8.1:1
Total Debt/Equity 1.64:1
Profitability
Gross Margin 86.8%
EBITDA Margin 18.5%
Profit Margin 6.9%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs